Mimedx (MDXG) Inventory Average (2011 - 2026)
Mimedx (MDXG) posted Inventory Average of $23.6 million for Q2 2026, down 8.55% sequentially from $25.8 million in Q1 2026, and down 3.68% YoY from $24.5 million in Q2 2025.
Mimedx (MDXG) Inventory Average (2011 - 2026) Analysis & Trends
Mimedx has reported Inventory Average for 15 years, with the latest figure at $23.6 million in Q2 2026.
- Quarterly Inventory Average fell 3.68% year-over-year to $23.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $23.6 million (down 3.68% YoY) and the FY2025 annual result came in at $24.6 million, up 9.63% from the prior year.
- Inventory Average declined to $23.6 million in Q2 2026 per MDXG's latest filing, from $25.8 million in the prior quarter.
- Over five years, Inventory Average peaked at $25.9 million in Q4 2025 and troughed at $12.3 million in Q1 2022.
- A 5-year average of $20.3 million and a median of $23.2 million in 2024 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2024 and 2026: Inventory Average surged 63.34% in 2024, then slipped 3.68% in 2026.
- Over 5 years, Inventory Average stood at $13.6 million in 2022, then jumped by 47.61% to $20.0 million in 2023, then rose by 19.87% to $24.0 million in 2024, then grew by 7.88% to $25.9 million in 2025, then dropped by 9.03% to $23.6 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $23.6 million, $25.8 million, and $25.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Mimedx | 622.24 Mn | 486.40 Mn | 44.38 Mn | 23.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.58 Mn |
| Mar 31, 2026 | 25.78 Mn |
| Dec 31, 2025 | 25.92 Mn |
| Sep 30, 2025 | 25.70 Mn |
| Jun 30, 2025 | 24.48 Mn |
| Mar 31, 2025 | 23.94 Mn |
| Dec 31, 2024 | 24.03 Mn |
| Sep 30, 2024 | 24.65 Mn |
| Jun 30, 2024 | 24.76 Mn |
| Mar 31, 2024 | 22.74 Mn |
| Dec 31, 2023 | 20.04 Mn |
| Sep 30, 2023 | 17.94 Mn |
| Jun 30, 2023 | 15.74 Mn |
| Mar 31, 2023 | 13.92 Mn |
| Dec 31, 2022 | 13.58 Mn |
| Sep 30, 2022 | 13.68 Mn |
| Jun 30, 2022 | 13.28 Mn |
| Mar 31, 2022 | 12.28 Mn |
| Dec 31, 2021 | 11.29 Mn |
| Sep 30, 2021 | 10.67 Mn |